title: Lymphadenoma of the salivary gland: clinicopathological and immunohistochemical analysis of 33 tumors.
abstract: Lymphadenomas (LADs) are rare salivary gland tumors. Their clinicopathologic characteristics and etiopathogenesis are poorly understood. We examined 33 LADs in 31 patients (17 women and 14 men) aged 11-79 years (median 65 years). There were 22 sebaceous LADs in 21 patients (9 women and 12 men) and 11 non-sebaceous LADs in 10 patients (8 women and 2 men). Two patients had synchronous double tumors. Twenty-six tumors (79%) arose in parotid, three in the neck, and two each in submandibular gland and oral cavity. Extraparotid tumors were seen in 2 of 21 (10%) patients with sebaceous and 4 of 10 (40%) patients with non-sebaceous LADs. Seven of twenty-three (30%) patients had immunosuppressive therapy for unrelated diseases. The tumors were well circumscribed, encapsulated (n=28, 84%) painless masses, varying in size from 0.6 to 6 cm (median 2.2). The cut surfaces were gray-tan to yellow, homogeneous and multicystic (n=24, 72%). The epithelial cells were basaloid, squamous and glandular, forming solid nests, cords, tubules, and cysts. Sebaceous differentiation was restricted to sebaceous lymphadenoma. The epithelial cells expressed basal cell markers (p63, 34BE12, and/or CK5/6, 18/18, 100%) and the luminal glandular cells expressed CK7 (12/12, 100%). Myoepithelial cells were absent (n=10/16, 63%) or focal. The lymphoid stroma was reactive, with germinal centers in 28 (84%). There was no evidence of HPV (0/11), EBV (0/7), and HHV-8 (0/8). Malignant transformation to sebaceous and basal cell adenocarcinoma was seen in one patient each. None of the 11 patients with follow-up (1-8 years) recurred. In summary, sebaceous and non-sebaceous LADs are benign, encapsulated, solid and cystic tumors affecting older adults. Non-sebaceous LADs affect women and extraparotid sites more frequently than sebaceous LADs. Altered immune status may have a role in their etiopathogenesis. Multiple synchronous tumors, origin in buccal mucosa, and malignant transformation may rarely occur.
authors: Department of Pathology, Presbyterian University Hospital, Pittsburgh, PA, USA.
authors: Raja R
authors: RR
authors: Seethala
authors: Lester D R
authors: LD
authors: Thompson
authors: Douglas R
authors: DR
authors: Gnepp
authors: E Leon
authors: EL
authors: Barnes
authors: Alena
authors: A
authors: Skalova
authors: Kathleen
authors: K
authors: Montone
authors: Shubhada
authors: S
authors: Kane
authors: James S
authors: JS
authors: Lewis
authors: Lynn W
authors: LW
authors: Solomon
authors: Roderick H W
authors: RH
authors: Simpson
authors: Ashraf
authors: A
authors: Khan
authors: Manju L
authors: ML
authors: Prasad
mesh_terms: D000230:Adenocarcinoma / Q000737:chemistry / Q000473:pathology; D018266:Adenocarcinoma, Sebaceous / Q000737:chemistry / Q000473:pathology; D000235:Adenolymphoma / Q000737:chemistry* / Q000276:immunology / Q000473:pathology* / Q000821:virology; D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D002471:Cell Transformation, Neoplastic / Q000737:chemistry / Q000473:pathology; D002648:Child; D004847:Epithelial Cells / Q000737:chemistry / Q000473:pathology; D005260:Female; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000737:chemistry* / Q000276:immunology / Q000473:pathology* / Q000821:virology; D027383:Papillomaviridae / Q000302:isolation & purification; D011379:Prognosis; D012468:Salivary Gland Neoplasms / Q000737:chemistry* / Q000276:immunology / Q000473:pathology* / Q000821:virology; D017154:Stromal Cells / Q000737:chemistry / Q000473:pathology; D013997:Time Factors; D047368:Tumor Burden; D014481:United States; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor